Image from Google Jackets

Normal view MARC view ISBD view

Access to experimental drugs in terminal illness: ethical issues.

By:

Schuklenk, Udo

Material type: Text

Text

TextLanguage: eng. Publication details: New York Pharmaceutical Products press, 1998Description: 228pISBN:

0789005638

Subject(s):

NLM classification:

QV 34: N98A: SCH

Average rating: 0.0 (0 votes)

Holdings ( 1 )
Comments ( 0 )

Holdings
Item type	Current library	Call number	Status	Date due	Barcode
Books	WHO Library	QV 34: N98A: SCH (Browse shelf(Opens below))	Available		6406

Browsing WHO Library shelves Close shelf browser (Hides shelf browser)

Previous	No cover image available		No cover image available			No cover image available		Next
Previous	QV 32-33: N97G: JAY Global drugs law. Selected papers presented at the Indian Law Institute/UNDCP/International Law Association, Regional Branch, India. International	QV 32-33: N98P: D'A Proceedings of the international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use: 4th: Brussels,	QV 33.1: N97H: MEH Handbook of drug laws.	QV 34: N98A: SCH Access to experimental drugs in terminal illness: ethical issues.	QV 38 2005CL Clinical pharmacology.	QV 38 2006IN Integrated pharmacology.	QV 38 2008ES Essentials of medical pharmacology.	Next

There are no comments on this title.

to post a comment.

Share

Copyright © 2022. All right reserved.

World Health House, Indraprastha Estate, Mahatma Gandhi Marg, New Delhi 110 002, India

Web: https://www.who.int/southeastasia | Email : searolibrary@who.int | Phone : 91-11-4304 0200 / 0161

Implemented & Customized by: OpenLX

Powered by Koha